The Application Methods of Mitogen-activated Protein Kinase Signal Pathway Inhibitors SP600125 and SB203580 in Long-term in Vivo Experiments

首页 > 成果 > 详情

认领

导出

Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Cai, H.;Chen, Q.*;Liu, Y.;Xie, H.;Lu, Q.;...

通讯作者：

Chen, Q.

作者机构：

[Cai, H.; Liu, Y.; Xie, H.; Chen, X.; Chen, Q.; Lu, Q.] Hunan Univ Tradit Chinese Med, Affiliated Hosp 1, Changsha 410007, Hunan, Peoples R China.

通讯机构：

[Chen, Q.] H

Hunan Univ Tradit Chinese Med, Affiliated Hosp 1, Changsha 410007, Hunan, Peoples R China.

语种：

英文

关键词：

C-Jun N-terminal kinase;in vivo;mitogen-activated protein kinases;p38;SB203580;SP600125

期刊：

WEST INDIAN MEDICAL JOURNAL

ISSN：

0043-3144

年：

2018

卷：

期：

页码：

98-104

DOI：

10.7727/wimj.2015.487

基金类别：

Chinese Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81173213]; Scientific Fund of Hunan Provincial Education Department, PRC [14A112]

机构署名：

本校为第一且通讯机构

院系归属：

第一中医临床学院

摘要：

Objective: To explore the application methods of mitogen-activated protein kinase signal pathway inhibitors SP600125 and SB203580 in long-term in vivo experiments. Methods: A total of 55 healthy New Zealand rabbits were randomly divided into blank control group, model control group, SP low dose group, SP high dose group, SP blank group, SB low dose group, SB high dose group, SB blank group, dimethyl sulfoxide (DMSO) control group, DMSO blank group, and positive control group. Since the first day of the experiment, each group was administered the corresponding treatment for four weeks continuou...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

The Application Methods of Mitogen-activated Protein Kinase Signal Pathway Inhibitors SP600125 and SB203580 in Long-term in Vivo Experiments

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问